scbmtБИОМЕДИЦИНАJournal Biomed2074-59822713-0428Scientific center of biomedical technologies of Federal Medical and Biological Agencyscbmt-771Research ArticleСтатьиВлияние алкоголя и психоактивных веществ
на приверженность и результаты лечения
больных ВИЧ-инфекциейМирошниковА. Е.noemail@neicon.ruХохловА. Л.noemail@neicon.ruАнтиповаН. П.noemail@neicon.ruЯрославская государственная медицинская академия, ЯрославльRussian FederationЦентр по профилактике и борьбе со СПИД и инфекционными заболеваниями, ЯрославльRussian Federation20101302202013102104Copyright © Мирошников А.Е., Хохлов А.Л., Антипова Н.П., 20202020Мирошников А.Е., Хохлов А.Л., Антипова Н.П.Мирошников А.Е., Хохлов А.Л., Антипова Н.П.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.scbmt.ru/jour/article/view/771ReferencesAIDS. 2008. - № 2: 109-128.AIDS. 2008. - № 2: 109-128.Nuñes MJ, Martin-Carbonero l, Moreno V, Valencia E, Garcia-Samaniego J, Gonzales-Castillo J, et al. Impact of antiretroviral treatment-related toxities on hospital admissions in HIV infected patients. AIDS Res Hum Retroviruses 2006; 22: 825-829.Nuñes MJ, Martin-Carbonero l, Moreno V, Valencia E, Garcia-Samaniego J, Gonzales-Castillo J, et al. Impact of antiretroviral treatment-related toxities on hospital admissions in HIV infected patients. AIDS Res Hum Retroviruses 2006; 22: 825-829.Patella F, Baker R, Moorman A, Chmiel J, Wood K, Brooks J, et al. tality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006; 43:27-43.Patella F, Baker R, Moorman A, Chmiel J, Wood K, Brooks J, et al. tality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006; 43:27-43.Tuldra A et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. Journal of Acquired Immune DeficiencySyndromes,2000, 25(3):221-228.Tuldra A et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. Journal of Acquired Immune DeficiencySyndromes,2000, 25(3):221-228.Walsh JC et al. Reasons for non- adherence to antiretroviral therapy: patients' perspectives provide evidence of multiple causes. AIDS Care, 2001, 13(6):709-720.Walsh JC et al. Reasons for non- adherence to antiretroviral therapy: patients' perspectives provide evidence of multiple causes. AIDS Care, 2001, 13(6):709-720.
The authors declare that there are no conflicts of interest present.